Benzinga | Jun 30, 2021 12:23PM EDT

Cytokinetics Publishes Study Titled 'A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) (COURAGE-ALS)' To ClinicalTrials.Gov Website

https://clinicaltrials.gov/ct2/show/NCT04944784